Jiong Shen
沈炯
Jiong Shen is a longtime partner at FreeS Fund, where he heads the firm's East China operations from Shanghai — described by the firm itself as an "old Shanghai hand" . His beat is healthcare and biotech: he has represented FreeS at its biopharma summits since at least 2020, in dialogue with industry figures like the head of Roche's Shanghai Innovation Center , and by 2023 he was writing as managing partner on the firm's interest in radiopharmaceuticals and cross-disciplinary projects . Founders he's backed remember him as an early believer — Shize Biotech's Li Xiang recalls arriving with "just a person, a PPT, and a backpack" when Shen agreed to support him . As of late 2024–2025 material he holds the title of managing partner, still focused on areas like anti-aging drugs and next-generation immunotherapy .
AI-generated — may contain errors, please verify.
Coverage
Is AI Healthcare Having Its DeepSeek Moment? | Frees VC Research
AI healthcare is becoming an open secret.
How to Seize the Development Opportunities in Next-Generation Immunotherapy? | See You in Shanghai on September 19
Welcome to sign up and participate
3/2 Suzhou Offline Event Registration | The 4th Biomedical Innovation and Translation Summit
Exploring the Path of Innovation and Translation in Biomedicine, Together
Nov 29 Shanghai Offline Event Registration | Anti-Aging New Drugs — Academic Seminar and Translational Salon
Let's decode aging, and fight it.
Decoding Aging, Combating Aging | FreeS Fund Report
The Secret of "Aging Without Decline"
Everything Has Two Sides: How Can "Nuclear Radiation" Be Used to Make Anti-Cancer Drugs? | FreeS Report 28
Now is the spring of radiopharmaceuticals.
Li Xiang, Founder of Shize Biotech: The Latest Intersection in Biotechnology — The Spring of Stem Cell Therapy | 2021 FreeS Fund Annual Investor Summit
How much longer until stem cell therapy brings hope to patients with serious diseases?
Biotech Firms Raise Nearly 4 Billion Yuan, Consumer Companies Land Over 1.4 Billion | FreeS Family Funding Roundup · August
We've also released three short videos this week — follow us to check them out.
FreeS Fund 2021 Outlook ② | Three Trends in Biomedical Innovation
The Biopharma Industry Enters the "Three Fast" Era
Blue Ocean Strategy: How Early-Stage Biopharma Startups Can Break Through and Win with Big Pharma | FreeS Fund 2020 Biopharma Summit Session 3 — Registration Open
From "Me Worse" to "First in Class": How Can Biopharma Companies Compete Through Differentiation?
Why Is AI Drug Discovery So Hot? And How Long Will It Stay Hot? | FreeS Fund Events & Research Recs
Three Slightly Brain-Burning Little Gifts
Li Feng: One Chart to Decode Biotech Innovation Opportunities | Your Complete Guide to the FreeS Fund 2020 Biomedical Summit
Three Livestreams and One Offline Symposium, Decoding the Era of Biomedical Innovation
Landing in Shanghai, Selling 100 Million Bags in 7 Months... 7 Companies Reach New Heights, Plus 4 Awards | FreeS Fund Blackboard · May
Do what's right, not what's easy.
FreeS Fund Sets Up Shop in Shanghai, New Office Now Operational
FreeS Fund opens offices in both the north and south, choosing to do what's right rather than what's easy.
Youth Takes Center Stage: 18 Career Advances and 20 Awards to Share | FreeS Fund Blackboard · April
May is May — and with it, infinite possibilities.
